<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://theherd.news/the-feed/fda-approves-first-veterinary-amlodipine-for-feline-hypertension</loc>
    <news:news>
      <news:publication>
        <news:name>The Herd</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-29</news:publication_date>
      <news:title>FDA approves first veterinary amlodipine for feline hypertension</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://theherd.news/the-feed/parasite-prevention-messaging-shifts-toward-trust-adherence-and-risk</loc>
    <news:news>
      <news:publication>
        <news:name>The Herd</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-29</news:publication_date>
      <news:title>Parasite prevention messaging shifts toward trust, adherence, and risk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://theherd.news/the-feed/abbvie-backs-kestrels-pan-kras-program-with-option-to-buy-deal</loc>
    <news:news>
      <news:publication>
        <news:name>The Herd</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-29</news:publication_date>
      <news:title>AbbVie backs Kestrel’s pan-KRAS program with option-to-buy deal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://theherd.news/the-feed/caredx-moves-into-oncology-with-planned-naveris-acquisition</loc>
    <news:news>
      <news:publication>
        <news:name>The Herd</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-29</news:publication_date>
      <news:title>CareDx moves into oncology with planned Naveris acquisition</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://theherd.news/the-feed/hutchmed-wins-priority-review-in-china-for-sovleplenib-in-waiha</loc>
    <news:news>
      <news:publication>
        <news:name>The Herd</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-29</news:publication_date>
      <news:title>HUTCHMED wins priority review in China for sovleplenib in wAIHA</news:title>
    </news:news>
  </url>
</urlset>